Get started
Author

Lynn Morrison

Observed names: L. Morrison, lynn morrison
OpenAlex ID: A5112415744
A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation
2013 · Stefan Verheye, John A. Ormiston, et al. · JACC: Cardiovascular Interventions · 166
PDF
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions
2016 · Alexandre Abizaid, Ricardo A. Costa, et al. · JACC: Cardiovascular Interventions · 110
PDF
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
2016 · Javaid Iqbal, Stefan Verheye, et al. · EuroIntervention · 22
TCT- 610 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results
2014 · Alexandre Abizaid, Joachim Schofer, et al. · Journal of the American College of Cardiology · 9
PDF
TCT-563 Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results
2012 · Stefan Verheye, Mark Webster, et al. · Journal of the American College of Cardiology · 9
PDF
TCT-32 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 4-Year Clinical and Imaging Results
2016 · Stefan Verheye, Lynn Morrison, et al. · Journal of the American College of Cardiology · 8
PDF
TCT-37 Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes
2013 · Alexandre Abizaid, Joachim Schofer, et al. · Journal of the American College of Cardiology · 7
TCT-330 Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results
2017 · Alexandre Abizaid, Mathias Vrolix, et al. · Journal of the American College of Cardiology · 5
TCT-16 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 5-Year Clinical and Imaging Results
2017 · Stefan Verheye, Joachim Schofer, et al. · Journal of the American College of Cardiology · 4
TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study
2016 · Holger Nef, Karl Eugen Hauptmann, et al. · Journal of the American College of Cardiology · 3
PDF
TCT-298 Six-month Intravascular Ultrasound Analysis of the DESolve FIM Trial with a Novel PLLA-based Fully Biodegradable Drug-eluting Scaffold
2012 · Jose Costa, John Ormiston, et al. · Journal of the American College of Cardiology · 3
PDF
Duraflex™ Drug-Eluting Coronary Stent System
2005 · Alexandre Abizaid, Vinayak Bhat, et al. · CRC Press eBooks · 3
TCT-17 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results
2015 · Stefan Verheye, Joachim Schofer, et al. · Journal of the American College of Cardiology · 2
PDF
TCT-583 Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation a Novolimus-Eluting Coronary Stent System with Bioabsorbable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: 12- Month Clinical and 6-Month Angiographic and IVUS Results: the EXCELLA BD Study
2012 · Alexandre Abizaid, Roberto Botelho, et al. · Journal of the American College of Cardiology · 2
PDF
TCT-331 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 24-month Results from the DESolve PMCF Study
2017 · Holger Nef, Azeem Latib, et al. · Journal of the American College of Cardiology · 1
PDF
TCT-460 Multi-Center, Randomized Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: Final 5-Year Results from the EXCELLA BD Study
2016 · Stefan Verheye, Alexandre Abizaid, et al. · Journal of the American College of Cardiology · 1
PDF
TCT-575 Multi-Center, Post-marketing Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System: 1-Year Results from the EXCELLA PMCF Study
2015 · Imad A. Alhaddad, Mohammad Jarrah, et al. · Journal of the American College of Cardiology · 1
TCT-515 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study
2015 · Holger Nef, Karl-Eugen Hauptmann, et al. · Journal of the American College of Cardiology · 1
PDF
TCT-419 Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions
2013 · Rodrigo A. Souza, Ricardo A. Costa, et al. · Journal of the American College of Cardiology · 1
PDF
CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results
2013 · Stefan Verheye, Mark Webster, et al. · JACC: Cardiovascular Interventions · 1
PDF
Abstract 18819: Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results
2012 · Stefan Verheye, mark webster, et al. · Circulation · 1
TCT-39 6-Month Angiographic Follow-up of the Novel DESolveTM Myolimus-Eluting Bioresorbable Coronary Scaffold for the Treatment of Non-Complex Coronary Lesions – Results from the DESolve I First-In-Man Trial
2012 · Ricardo Costa, Alexandre Abizaid, et al. · Journal of the American College of Cardiology · 1
PDF
TCT-302 Evaluation of the Novel DESolve Myolimus-Eluting Bioresorbable Coronary Scaffold System for Treatment of De Novo Coronary Arteries: Six-Month Optical Coherence Tomography Results from the DESolve FIM Trial
2012 · Daniel Chamie, Jose Costa, et al. · Journal of the American College of Cardiology · 1
PDF
The DESolve scaffold
2017 · Stefan Verheye, Nagarajan Ramesh, et al. · CRC Press eBooks
TCT-568 Multi-Center, Randomized Evaluation of the Elixir DESyne® Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: 4-Year Results from the EXCELLA BD Study®
2015 · Stefan Verheye, Alexandre Abizaid, et al. · Journal of the American College of Cardiology
Works count: 42
Citation count: 362
H-index: 7
I10-index: 3
Year
Topic
Type